Editorial: Genotype 3 HCV-who Still Needs Ribavirin in a Pan-Genotypic Era? Authors’ Reply
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14648
Full Text
Open PDFAbstract
Available in full text
Date
May 17, 2018
Authors
Publisher
Wiley